2021. THE POTENTIAL OF CHIMERIC ANTIGEN RECEPTOR T CELL (CART-T CELL) TARGETTING PROSTATE-SPECIFIC MEMRANE ANTIGEN (PSMA) MODIFIED BY CRISPR/CAS9 AS PROSTATE CANCER THERAPY. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia. 9, 1 (Jul. 2021), 23–37. DOI:https://doi.org/10.53366/jimki.v9i1.321.